Wei Ou
Impact in
-
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Geriatrics and Gerontology top 10%
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Ferroptosis and cancer prognosis 4
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Tao Li (7 shared papers)Maodi Xie (7 shared papers)Qian Li (3 shared papers)Yu Liang (5 shared papers)Yan Deng (5 shared papers)Hai Yu (3 shared papers)Chunling Jiang (2 shared papers)Yanyi Zheng (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Frontiers in Immunology (2 papers)The Prostate (1 paper)Cellular Immunology (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Ou
36 papers receiving 721 citations
Wei Ou's Hit Papers
Peers
Comparison fields: 5 of 89
- Cardiology and Cardiovascular Medicine 185
- Geriatrics and Gerontology 28
- Physiology 140
- Developmental Neuroscience 16
- Cancer Research 56
Countries citing papers authored by Wei Ou
This map shows the geographic impact of Wei Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ou more than expected).
Fields of papers citing papers by Wei Ou
This network shows the impact of papers produced by Wei Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ou. The network helps show where Wei Ou may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Ou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF Hit paper breakdown → | 2020 | 319 |
| 2 | 2021 | 61 | |
| 3 | 2022 | 50 | |
| 4 | 2017 | 36 | |
| 5 | 2023 | 30 | |
| 6 | 2021 | 23 | |
| 7 | 2022 | 22 | |
| 8 | 2011 | 21 | |
| 9 | 2005 | 19 | |
| 10 | 2020 | 15 | |
| 11 | 2023 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2016 | 8 | |
| 17 | 2018 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2015 | 7 | |
| 20 | 2009 | 6 |
About Wei Ou
Wei Ou is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 38 papers that have together received 727 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Ferroptosis and cancer prognosis (4 papers), Anesthesia and Neurotoxicity Research (3 papers), Lung Cancer Research Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Metal and Thin Film Mechanics (2 papers), Anesthesia and Sedative Agents (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (185 citations), Geriatrics and Gerontology (28 citations), Physiology (140 citations), Developmental Neuroscience (16 citations) and Cancer Research (56 citations). Wei Ou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Tao Li, Maodi Xie, Qian Li, Yu Liang, Yan Deng, Hai Yu, Chunling Jiang, Yanyi Zheng, Shisheng Wang and Haitao Xiao. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology, The Prostate, Cellular Immunology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.